US Stock MarketDetailed Quotes

GERN Geron

Watchlist
  • 1.700
  • -0.050-2.86%
Close Mar 25 16:00 ET
  • 1.700
  • 0.0000.00%
Post 20:01 ET
1.08BMarket Cap-6.30P/E (TTM)

About Geron Company

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Company Profile

SymbolGERN
Company NameGeron
Listing DateJul 30, 1996
Issue Price8.00
Founded1990
CEOMs. Dawn Carter Bir
MarketNASDAQ
Employees229
Fiscal Year Ends12-31
Address919 East Hillsdale Boulevard,Suite 250
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-473-7700
Websitehttp://www.geron.com

Company Executives

  • Name
  • Position
  • Salary
  • Dawn Carter Bir
  • Director, Interim President and Chief Executive Officer
  • 343.12K
  • Dr. Andrew J. Grethlein,PhD
  • Executive Vice President and Chief Operating Officer
  • 2.42M
  • Michelle Robertson
  • Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 2.47M
  • Melissa A. Kelly Behrs
  • Executive Vice President, Business Operations and Chief Alliance Officer
  • --
  • Edward E. Koval
  • Executive Vice President and Chief Business Officer
  • --
  • Scott A. Samuels
  • Executive Vice President, Chief Legal Officer and Corporate Secretary
  • 3.61M
  • Shannon T. Odam
  • Senior Vice President and Chief People Officer
  • --
  • James Ziegler
  • Executive Vice President and Chief Commercial Officer
  • --
  • Dr. Faye Feller, M.D.
  • Executive Vice President and Chief Medical Officer
  • --
  • Dr. Joseph Emile Eid
  • Executive Vice President, Research and Development
  • --
  • Elizabeth G. O’Farrell
  • Chairman of the Board and Lead Independent Director
  • 375.53K
  • Dr. V. Bryan Lawlis, PhD
  • Independent Director
  • 360.90K
  • John F. McDonald
  • Independent Director
  • 348.40K
  • Dr. Robert J. Spiegel, F.A.C.P.,M.D.
  • Independent Director
  • 350.90K
  • Dr. Gaurav Aggarwal, M.D.
  • Independent Director
  • 290.82K
  • Dr. Susan M. Molineaux, PhD
  • Independent Director
  • 345.90K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Enerpac Tool
EPAC
47.020
Precision Drilling
PDS
46.910
Halozyme Therapeutics
HALO
64.840
4
Workday
WDAY
252.830
5
Lantheus
LNTH
99.770
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings